Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Gallerano, Daniela ^a   Ndlovu, Portia ^b   Makupe, Ian ^b   Focke Tejkl, Margarete ^a   Fauland, Kerstin ^c   Wollmann, Eva ^a   Puchhammer Stöckl, Elisabeth ^a   Keller, Walter ^c   Sibanda, Elopy ^d   Valenta, Rudolf ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Gamma City Laboratory   (Zimbabwe)

^c UNIVERSITY OF GRAZ   (Austria)

^d Parirenyatwa CRS   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M; INTEGRASE; PROTEINASE; RIBONUCLEASE H; RNA DIRECTED DNA POLYMERASE; PROTEOME;

AFRICAN; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CELL LOSS; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; EUROPEAN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; IMMUNOREACTIVITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; T LYMPHOCYTE; TH1 TH2 BALANCE; VIRUS CAPSID; ADULT; AFRICA; AGED; ANTIBODY PRODUCTION; COMPARATIVE STUDY; EUROPE; FEMALE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MALE; MIDDLE AGED; MOLECULAR MODEL;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

ADULT; AFRICA; AGED; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; EUROPE; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; MODELS, MOLECULAR; PROTEOME;

EID: 84922572549     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117204     Document Type: Article

References (57)

1. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, et al. (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305(24): 1425-31. PMID: 6272109
2. Masur H, Michelis MA, Greene JB, Onorato I, Stouwe RA, et al. (1981) An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med 305(24): 1431-8. PMID: 6975437
3. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre MT, Chamaret S, et al. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220 (4599): 868-71. PMID: 6189183
4. Rowland-Jones SL (2003) Timeline: AIDS pathogenesis: what have two decades of HIV research taught us? Nat Rev Immunol 3(4): 343-8. PMID: 12669024
5. Ratner L, Gallo RC, Wong-Staal F (1985) HTLV-III, LAV, ARV are variants of same AIDS virus. Nature 313(6004):636-7. PMID: 3974696
6. Munier ML, Kelleher AD (2007) Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection. Immunol Cell Biol 85(1): 6-15. PMID: 17146463
7. Grossman Z, Meier-Schellersheim M, Sousa AE, Victorino RM, Paul WE (2002) CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause? Nat Med 8(4): 319-23. PMID: 11927927
8. Bjorndal A, Deng H, Jansson M, Fiore JR, Colognesi C, et al. (1997) Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J Virol 71(10): 7478-87. PMID: 9311827
9. Kowalski M, Potz J, Basiripour L, Dorfman T, Goh WC, et al. (1987) Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237(4820): p. 1351-5. PMID: 3629244
10. Zhu P, Liu J, Bess J Jr, Chertova E, Lifson JD, et al. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441(7095): 847-52. PMID: 16728975
11. Roux KH, Taylor KA (2007) AIDS virus envelope spike structure. Curr Opin Struct Biol 17(2): 244-52. PMID: 17395457
12. Burton DR, Poignard P, Stanfield RL, Wilson IA (2012) Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337(6091): 183-6. doi: 10.1126/science.1225416 PMID: 22798606
13. Klein F, Gaebler C, Mouquet H, Sather DN, Lehmann C, et al. (2012) Broad neutralization by a combination of antibodies recognizing the CD4 binding site and a new conformational epitope on the HIV-1 envelope protein. J Exp Med 209(8): 1469-79. doi: 10.1084/jem.20120423 PMID: 22826297
14. McCoy LE, Weiss RA (2013) Neutralizing antibodies to HIV-1 induced by immunization. J Exp Med 210(2): 209-23. doi: 10.1084/jem.20121827 PMID: 23401570
15. Taylor BS, Sobieszczyk ME, McCutchan FE, Hammer SM (2008) The challenge of HIV-1 subtype diversity. N Engl J Med 358(15): 1590-602. doi: 10.1056/NEJMra0706737 PMID: 18403767
16. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, et al. (2009) A new human immunodeficiency virus derived from gorillas. Nat Med 15(8): 871-2. doi: 10.1038/nm.2016 PMID: 19648927
17. Hemelaar J, Gouws E, Ghys PD, Osmanov S, WHO-UNAIDS Network for HIV Isolation and Characterisation (2011) Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 25(5): 679-89. doi: 10.1097/QAD.0b013e328342ff93 PMID: 21297424
18. Dalai SC, de Oliveira T, Harkins GW, Kassaye SG, Lint J, et al. (2009) Evolution and molecular epidemiology of subtype C HIV-1 in Zimbabwe. AIDS 23(18): 2523-32. doi: 10.1097/QAD. 0b013e3283320ef3 PMID: 19770693
19. Huang A, Hogan JW, Istrail S, Delong A, Katzenstein DA, et al. (2012) Global analysis of sequence diversity within HIV-1 subtypes across geographic regions. Future Virol 7(5): 505-517. PMID: 22822410
20. Gnann JW Jr, McCormick JB, Mitchell S, Nelson JA, Oldstone MB (1987) Synthetic peptide immunoassay distinguishes HIV type 1 and HIV type 2 infections. Science 237(4820): 1346-9. PMID: 2888192
21. Palker TJ, Matthews TJ, Clark ME, Cianciolo GJ, Randall RR, et al. (1987) A conserved region at the COOH terminus of human immunodeficiency virus gp120 envelope protein contains an immunodominant epitope. Proc Natl Acad Sci U S A 84(8): 2479-83. PMID: 2436231
22. Klasse PJ, Pipkorn R, Blomberg J (1988) Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc Natl Acad Sci U S A 85(14): 5225-9. PMID: 2455899
23. Goudsmit J, Meloen RH, Brasseur R (1990) Map of sequential B cell epitopes of the HIV-1 transmembrane protein using human antibodies as probe. Intervirology 31(6): 327-38. PMID: 1704000
24. Loomis-Price LD, Cox JH, Mascola JR, Van Cott TC, Michael NL, et al. (1998) Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in earlystage infection. J Infect Dis 178(5): 1306-16. PMID: 9780250
25. Gottardo R, Bailer RT, Korber BT, Gnanakaran S, Phillips J, et al. (2013) Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial. PLoS One 8(9): e75665. doi: 10.1371/journal.pone.0075665 PMID: 24086607
26. Focke M, Mahler V, Ball T, Sperr WR, Majlesi Y, et al. (2001) Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination. FASEB J 15(11): 2042-4. PMID: 11511525
27. Gallerano D, Devanaboyina SC, Swoboda I, Linhart B, Mittermann I, et al. (2011) Biophysical characterization of recombinant HIV-1 subtype C virus infectivity factor. Amino Acids 40(3): 981-9. doi: 10.1007/s00726-010-0725-x PMID: 20809132
28. Rodenburg CM, Li Y, Trask SA, Chen Y, Decker J, et al. (2001) Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses 17(2): 161-8. PMID: 11177395
29. Hiller R, Laffer S, Harwanegg C, Huber M, Schmidt WM, et al. (2002) Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 16(3): 414-6. PMID: 11790727
30. Arnold K, Bordoli L, Kopp J, Schwede T (2006) The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 22(2): 195-201. PMID: 16301204
31. Emsley P, Lohkamp B, Scott WG, Cowtan K (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66(Pt 4): 486-501. doi: 10.1107/S0907444910007493 PMID: 20383002
32. Jones DT (1999) Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol 292(2): 195-202. PMID: 10493868
33. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, et al. (2007) Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 445(7129): 732-7. PMID: 17301785
34. Hwang SS, Boyle TJ, Lyerly HK, Cullen BR (1991) Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253(5015): 71-4. PMID: 1905842
35. Wu L, Gerard NP, Wyatt R, Choe H, Parolin C, et al. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384(6605): 179-83. PMID: 8906795
36. Gnann JW Jr, Nelson JA, Oldstone MB (1987) Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. J Virol 61(8): 2639-41. PMID: 2439707
37. Haffar OK, Dowbenko DJ, Berman PW (1988) Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes. J Cell Biol 107(5): 1677-87. PMID: 3053734
38. Postler TS, Desrosiers RC (2013) The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J Virol 87(1): 2-15. doi: 10.1128/JVI.02053-12 PMID: 23077317
39. Snapper CM, Paul WE (1987) Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236(4804): 944-7. PMID: 3107127
40. Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, et al. (1990) Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8: 303-33. PMID: 1693082
41. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, et al. (2012) Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 366(14): 1275-86. doi: 10.1056/NEJMoa1113425 PMID: 22475592
42. Briggs JA, Simon MN, Gross I, Kräusslich HG, Fuller SD, et al. (2004) The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 11(7): 672-5. PMID: 15208690
43. Hill M, Tachedjian G, Mak J (2005) The packaging and maturation of the HIV-1 Pol proteins. Curr HIV Res 3(1): 73-85. PMID: 15638725
44. Welker R, Kottler H, Kalbitzer HR, Kräusslich HG (1996) Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219(1): 228-36. PMID: 8623533
45. Liu H, Wu X, Newman M, Shaw GM, Hahn BH, et al. (1995) The Vif protein of human and simian immunodeficiency viruses is packaged into virions and associates with viral core structures. J Virol 69(12): 7630-8. PMID: 7494271
46. Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, et al. (1994) Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 265(5169): 248-52. PMID: 8023143
47. Sarih M, Maataoui WE, Benslimane A (1996) Analysis of apoptosis and a Th1/Th2 phenotype in HIV-infected patients. Immunol Lett 50(3): 125-9. PMID: 8803608
48. Douglas SD, Durako S, Sullivan KE, Camarca M, Moscicki AB, et al. (2003) TH1 and TH2 cytokine mRNA and protein levels in human immunodeficiency virus (HIV)-seropositive and HIV-seronegative youths. Clin Diagn Lab Immunol 10(3): 399-404. PMID: 12738638
49. Wan YY, Flavell RA (2009) How diverse-CD4 effector T cells and their functions. J Mol Cell Biol 1(1): 20-36. doi: 10.1093/jmcb/mjp001 PMID: 19482777
50. Nusslein HG, Spiegelberg HL (1990) Interleukin-4 induces both IgG4 and IgE secretion by peripheral blood B cells. J Clin Lab Anal 4(6): 414-9. PMID: 2126556
51. Kitani A, Strober W (1993) Regulation of C gamma subclass germ-line transcripts in human peripheral blood B cells. J Immunol 151(7): 3478-88. PMID: 8376788
52. Kawano Y, Noma T, Yata J (1994) Regulation of human IgG subclass production by cytokines. IFNgamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 153(11): 4948-58. PMID: 7963558
53. Lupinek C, Wollmann E, Baar A, Banerjee S, Breiteneder H, et al. (2014) Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 66(1): 106-19. doi: 10.1016/j.ymeth.2013.10.008 PMID: 24161540
54. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, et al. (2002) Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat Med 8(3): 295-301. PMID: 11875502
55. Linhart B, Bigenzahn S, Hartl A, Lupinek C, Thalhamer J, et al. (2007) Costimulation blockade inhibits allergic sensitization but does not affect established allergy in a murine model of grass pollen allergy. J Immunol 178(6): 3924-31. PMID: 17339493
56. Marth K, Wollmann E, Gallerano D, Ndlovu P, Makupe I, et al. (2014) Persistence of IgE-associated allergy and allergen-specific IgE despite CD4+ T cell loss in AIDS. PLoS One 4; 9(6):e97893. doi: 10.1371/journal.pone.0097893 PMID: 24896832
57. Leclerc C, Sedlik C, Lo-Man R, Charlot B, Rojas M, et al. (1995) Stimulation of a memory B cell response does not require primed helper T cells. Eur J Immunol 25(9): 2533-8. PMID: 7589122